Assessment of the 2010 global measles mortality reduction goal

Results from a model of surveillance data

Emily Simons, Matthew Ferrari, John Fricks, Kathleen Wannemuehler, Abhijeet Anand, Anthony Burton, Peter Strebel

Research output: Contribution to journalArticle

184 Citations (Scopus)

Abstract

Background: In 2008 all WHO member states endorsed a target of 90 reduction in measles mortality by 2010 over 2000 levels. We developed a model to estimate progress made towards this goal. Methods: We constructed a state-space model with population and immunisation coverage estimates and reported surveillance data to estimate annual national measles cases, distributed across age classes. We estimated deaths by applying age-specific and country-specific case-fatality ratios to estimated cases in each age-country class. Findings: Estimated global measles mortality decreased 74 from 535 300 deaths (95 CI 347 200-976 400) in 2000 to 139 300 (71 200-447 800) in 2010. Measles mortality was reduced by more than three-quarters in all WHO regions except the WHO southeast Asia region. India accounted for 47 of estimated measles mortality in 2010, and the WHO African region accounted for 36. Interpretation: Despite rapid progress in measles control from 2000 to 2007, delayed implementation of accelerated disease control in India and continued outbreaks in Africa stalled momentum towards the 2010 global measles mortality reduction goal. Intensified control measures and renewed political and financial commitment are needed to achieve mortality reduction targets and lay the foundation for future global eradication of measles. Funding: US Centers for Disease Control and Prevention (PMS 5U66/IP000161).

Original languageEnglish (US)
Pages (from-to)2173-2178
Number of pages6
JournalThe Lancet
Volume379
Issue number9832
DOIs
StatePublished - Jun 2012
Externally publishedYes

Fingerprint

Measles
Mortality
India
Space Simulation
Southeastern Asia
Centers for Disease Control and Prevention (U.S.)
Disease Outbreaks
Immunization
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Assessment of the 2010 global measles mortality reduction goal : Results from a model of surveillance data. / Simons, Emily; Ferrari, Matthew; Fricks, John; Wannemuehler, Kathleen; Anand, Abhijeet; Burton, Anthony; Strebel, Peter.

In: The Lancet, Vol. 379, No. 9832, 06.2012, p. 2173-2178.

Research output: Contribution to journalArticle

Simons, E, Ferrari, M, Fricks, J, Wannemuehler, K, Anand, A, Burton, A & Strebel, P 2012, 'Assessment of the 2010 global measles mortality reduction goal: Results from a model of surveillance data', The Lancet, vol. 379, no. 9832, pp. 2173-2178. https://doi.org/10.1016/S0140-6736(12)60522-4
Simons, Emily ; Ferrari, Matthew ; Fricks, John ; Wannemuehler, Kathleen ; Anand, Abhijeet ; Burton, Anthony ; Strebel, Peter. / Assessment of the 2010 global measles mortality reduction goal : Results from a model of surveillance data. In: The Lancet. 2012 ; Vol. 379, No. 9832. pp. 2173-2178.
@article{0a3e5ccf2b824414aa415c8ec1a7003f,
title = "Assessment of the 2010 global measles mortality reduction goal: Results from a model of surveillance data",
abstract = "Background: In 2008 all WHO member states endorsed a target of 90 reduction in measles mortality by 2010 over 2000 levels. We developed a model to estimate progress made towards this goal. Methods: We constructed a state-space model with population and immunisation coverage estimates and reported surveillance data to estimate annual national measles cases, distributed across age classes. We estimated deaths by applying age-specific and country-specific case-fatality ratios to estimated cases in each age-country class. Findings: Estimated global measles mortality decreased 74 from 535 300 deaths (95 CI 347 200-976 400) in 2000 to 139 300 (71 200-447 800) in 2010. Measles mortality was reduced by more than three-quarters in all WHO regions except the WHO southeast Asia region. India accounted for 47 of estimated measles mortality in 2010, and the WHO African region accounted for 36. Interpretation: Despite rapid progress in measles control from 2000 to 2007, delayed implementation of accelerated disease control in India and continued outbreaks in Africa stalled momentum towards the 2010 global measles mortality reduction goal. Intensified control measures and renewed political and financial commitment are needed to achieve mortality reduction targets and lay the foundation for future global eradication of measles. Funding: US Centers for Disease Control and Prevention (PMS 5U66/IP000161).",
author = "Emily Simons and Matthew Ferrari and John Fricks and Kathleen Wannemuehler and Abhijeet Anand and Anthony Burton and Peter Strebel",
year = "2012",
month = "6",
doi = "10.1016/S0140-6736(12)60522-4",
language = "English (US)",
volume = "379",
pages = "2173--2178",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9832",

}

TY - JOUR

T1 - Assessment of the 2010 global measles mortality reduction goal

T2 - Results from a model of surveillance data

AU - Simons, Emily

AU - Ferrari, Matthew

AU - Fricks, John

AU - Wannemuehler, Kathleen

AU - Anand, Abhijeet

AU - Burton, Anthony

AU - Strebel, Peter

PY - 2012/6

Y1 - 2012/6

N2 - Background: In 2008 all WHO member states endorsed a target of 90 reduction in measles mortality by 2010 over 2000 levels. We developed a model to estimate progress made towards this goal. Methods: We constructed a state-space model with population and immunisation coverage estimates and reported surveillance data to estimate annual national measles cases, distributed across age classes. We estimated deaths by applying age-specific and country-specific case-fatality ratios to estimated cases in each age-country class. Findings: Estimated global measles mortality decreased 74 from 535 300 deaths (95 CI 347 200-976 400) in 2000 to 139 300 (71 200-447 800) in 2010. Measles mortality was reduced by more than three-quarters in all WHO regions except the WHO southeast Asia region. India accounted for 47 of estimated measles mortality in 2010, and the WHO African region accounted for 36. Interpretation: Despite rapid progress in measles control from 2000 to 2007, delayed implementation of accelerated disease control in India and continued outbreaks in Africa stalled momentum towards the 2010 global measles mortality reduction goal. Intensified control measures and renewed political and financial commitment are needed to achieve mortality reduction targets and lay the foundation for future global eradication of measles. Funding: US Centers for Disease Control and Prevention (PMS 5U66/IP000161).

AB - Background: In 2008 all WHO member states endorsed a target of 90 reduction in measles mortality by 2010 over 2000 levels. We developed a model to estimate progress made towards this goal. Methods: We constructed a state-space model with population and immunisation coverage estimates and reported surveillance data to estimate annual national measles cases, distributed across age classes. We estimated deaths by applying age-specific and country-specific case-fatality ratios to estimated cases in each age-country class. Findings: Estimated global measles mortality decreased 74 from 535 300 deaths (95 CI 347 200-976 400) in 2000 to 139 300 (71 200-447 800) in 2010. Measles mortality was reduced by more than three-quarters in all WHO regions except the WHO southeast Asia region. India accounted for 47 of estimated measles mortality in 2010, and the WHO African region accounted for 36. Interpretation: Despite rapid progress in measles control from 2000 to 2007, delayed implementation of accelerated disease control in India and continued outbreaks in Africa stalled momentum towards the 2010 global measles mortality reduction goal. Intensified control measures and renewed political and financial commitment are needed to achieve mortality reduction targets and lay the foundation for future global eradication of measles. Funding: US Centers for Disease Control and Prevention (PMS 5U66/IP000161).

UR - http://www.scopus.com/inward/record.url?scp=84861940891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861940891&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(12)60522-4

DO - 10.1016/S0140-6736(12)60522-4

M3 - Article

VL - 379

SP - 2173

EP - 2178

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9832

ER -